1737 — Taiyen Biotech Co Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesConservativeSmall CapContrarian

Annual balance sheet for Taiyen Biotech Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,891	2,084	1,887	1,840	1,938
Net Total Accounts Receivable
Net Total Receivables	541	758	650	663	498
Total Inventory
Total Other Current Assets
Total Current Assets	2,900	3,395	3,094	3,026	2,927
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3,431	3,564	3,713	3,907	4,025
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	7,798	8,468	8,212	8,320	8,381
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	695	1,305	926	1,101	1,165
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	1,568	2,106	1,690	1,829	1,717
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	6,229	6,361	6,521	6,491	6,664
Total Liabilities & Shareholders' Equity	7,798	8,468	8,212	8,320	8,381
Total Common Shares Outstanding